lancet: Covaxin safe for kids aged 2-18, found as effective as in adults: Lancet
Bharat Biotech's locally developed Covid-19 vaccine, Covaxin, has proven to be safe, well-tolerated and highly immunogenic in children aged 2-18 years in phase 2/3 trials, according to the results of the study published in the Lancet…